Non-coding RNAs in depression: Promising diagnostic and therapeutic biomarkers

EBioMedicine. 2021 Sep:71:103569. doi: 10.1016/j.ebiom.2021.103569. Epub 2021 Sep 11.

Abstract

Non-coding RNAs (ncRNAs), including microRNAs, circular RNAs, and long non-coding RNAs, are important regulators of normal biological processes and their abnormal expression may be involved in the pathogenesis of human diseases including depression. Multiple studies have demonstrated a significantly increased or reduced ncRNAs expression in depressed patients compared with healthy subjects and that antidepressant therapy can alter the aberrant expression of ncRNAs in depressed patients. Although the existing evidence is important, it is also mixed and a comprehensive review to guide an effective clinical translation is lacking. Focused on human research, this review summarizes clinical findings of ncRNAs in depression, including those in brain tissues and peripheral samples. We outlined the characteristics and functions of ncRNAs and highlighted their performance in the diagnosis and treatment of depression. Although their precise roles in depression remain uncertain, ncRNAs have shown potential value as biomarkers for diagnosis and therapy in depressed patients.

Keywords: Biomarker; Circular RNAs; Depression; Long non-coding RNAs; MicroRNAs; Non-coding RNAs.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers*
  • Cell-Free Nucleic Acids
  • Depression / diagnosis
  • Depression / etiology*
  • Depression / metabolism
  • Depression / therapy
  • Disease Susceptibility
  • Drug Development
  • Gene Expression Regulation*
  • Gene Regulatory Networks
  • Humans
  • MicroRNAs / genetics
  • Molecular Diagnostic Techniques
  • Molecular Targeted Therapy
  • Prognosis
  • RNA Interference
  • RNA, Circular
  • RNA, Long Noncoding*

Substances

  • Biomarkers
  • Cell-Free Nucleic Acids
  • MicroRNAs
  • RNA, Circular
  • RNA, Long Noncoding